Insider Stock Trading History of Dylan-hyde Tyler


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Dylan-hyde Tyler since year 2005. The trader's CIK number is 1682027. At the time of this reporting, Dylan-hyde Tyler is the Chief Legal Officer of Crispr Therapeutics Ag . (stock ticker symbol CRSP). See this page for all insider trading activities at Crispr Therapeutics Ag .


Stock purchases, sales, and option exercises reported by insider Dylan-hyde Tyler since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-04 CRSP Crispr Therapeutics Ag Sale 477 18.55 8,848
2017-08-07 CRSP Crispr Therapeutics Ag Sale 13,210 18.56 245,204
2017-08-08 CRSP Crispr Therapeutics Ag Sale 1,313 18.60 24,421
2017-05-01 CRSP Crispr Therapeutics Ag Sale 1,852 16.61 30,754
2017-04-26 CRSP Crispr Therapeutics Ag Sale 3,200 16.76 53,641
2017-04-27 CRSP Crispr Therapeutics Ag Sale 13,527 16.84 227,794
2017-04-28 CRSP Crispr Therapeutics Ag Sale 4,912 16.62 81,637
2017-04-21 CRSP Crispr Therapeutics Ag Sale 3,010 17.02 51,221
2017-04-24 CRSP Crispr Therapeutics Ag Sale 3,522 16.44 57,898
2017-04-25 CRSP Crispr Therapeutics Ag Sale 4,800 16.87 80,990
2017-04-19 CRSP Crispr Therapeutics Ag Sale 7,240 18.04 130,587
2017-04-20 CRSP Crispr Therapeutics Ag Sale 2,937 17.37 51,024

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dylan-hyde Tyler (Chief Legal Officer of Crispr Therapeutics Ag at the time of this reporting) see the Securities and Exchange Commission (SEC) website.